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A B S T R A C T
Stress radionuclide myocardial perfusion scintigraphy (MPS) with the use of single 
photon emission computed tomography (SPECT) is a widely established method for 
the detection of coronary artery disease, patient management and patient risk stratifi-
cation, as well as evaluation of revascularization results. MPS SPECT is traditionally 
being performed with patients in the supine position. This practice is, however, as-
sociated with various soft tissue attenuation artifacts, resulting in reduced test speci-
ficity. Various methods have been investigated to deal with this problem including 
the inspection of planar projection images, the integration of wall motion and wall 
thickening information from gated MPS, the application of transmission attenuation 
maps from radionuclide sources and the MPS SPECT with the patient in prone posi-
tion. Most of the above methods suffer from several limitations. However, the addition 
of prone acquisition to traditional supine MPS SPECT has been proven to be an easy 
and efficient way to reduce attenuation artifacts (concerning mainly the inferior wall) 
leading to a significant improvement in the specificity of this imaging technique.
I N T R O D U C T I O N
Stress radionuclide myocardial perfusion scintigraphy (MPS) with the use of single 
photon emission computed tomography (SPECT) is a widely established method for 
the detection of coronary artery disease (CAD), patient management and patient risk 
stratification, as well as evaluation of revascularization results. The sensitivity of this 
test for the detection of angiographically significant (more than 50% stenosis) CAD was 
estimated to be 87%, while the specificity was 73%.1 MPS SPECT has also important 
prognostic implications. In a large series of more than 4500 intermediate-high risk 
CAD patients, a normal 99mTc-Tetrofosmin study corresponded to an annualised car-
diac death rate of less than 1% (in particular 0.6%).2 Prior published studies reported 
excellent survival rates (ranging from 99.3% to 99.7%) for more than 10,000 patients 
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with normal 201Tl or 99mTc-sestamibi SPECT studies.3-5
MPS SPECT is traditionally being performed with patients 
in the supine position. This practice is, however, associated 
with various soft tissue attenuation artifacts, resulting in 
reduced test specificity. Diaphragmatic attenuation of the 
inferior wall mainly in obese patients6 and breast attenuation 
of the anterior wall in females may cause false-positive inferior 
and anterior wall defects respectively. Various methods have 
been investigated to deal with this problem.
M E T H O D S  T O  D E C R E A S E  P E R F U S I O N 
A R T I F A C T S
The inspection of planar projection images can help in 
identifying photon attenuation in the inferior wall due to 
the left hemidiaphragm, or in the anterior wall in females 
(breast attenuation artefact).7 However, relying exclusively 
on planar images-which are of suboptimal quality- for this 
purpose is likely to reduce sensitivity for the detection of 
true abnormalities and additional planar image acquisition 
makes the test extremely time consuming, mainly affecting 
patient throughput.
The integration of wall motion and wall thickening infor-
mation from gated MPS may improve diagnostic performance 
of SPECT and effectively differentiates artifacts from true 
perfusion defects in equivocal fixed defects.8-9 Gated SPECT 
provide us with high quality myocardial perfusion images 
together with a considerable amount of data related to the 
performance of the left ventricle (LV): analysis of regional 
wall motion and quantification of global function by estimating 
LV end-diastolic volume, LV end-systolic volume, LV stroke 
volume, and LV ejection fraction.10 This approach has already 
proven useful in tissue characterization and prediction of out-
come.11 Choi et al8 found that reviewing gated images along 
with tomographic perfusion images in patients with equivocal 
fixed defects resulted in improvement in specificity (from 86% 
to 92%), sensitivity (from 72% to 80%) and interobserver 
agreement. Smanio et al9 demonstrated that the integration of 
gated cine images to rest–stress perfusion images reduced the 
number of borderline interpretations. However, gated SPECT 
is not considered a final solution because, by interpreting fixed 
defects as significant only when associated with abnormal 
contraction, true myocardial perfusion defects due to subendo-
cardial infarction without associated contraction abnormality 
might be falsely attributed to soft-tissue attenuation.12
An alternative method to resolve attenuation artefacts is 
by applying transmission attenuation maps from radionuclide 
sources.13 Although this technique results in significant im-
provements in specificity and normalcy rates of MPS SPECT, 
it is limited by a number of factors: the physical decay of ra-
dionuclide source over time, hence the need for replacement, 
the installation of specialized hardware and software, the cost 
and the limited availability. An evolution to this issue is the 
application of attenuation correction maps generated by X-ray 
sources integrated in modern hybrid SPECT-CT systems;14 
however, such systems are also not widely available.
M P S  S P E C T  W I T H  T H E  P A T I E N T  I N 
P R O N E  P O S I T I O N
MPS SPECT with the patient in prone position (prone 
SPECT) is an easy and efficient way to reduce attenuation 
and motion artifacts and subsequently increases specificity of 
typical supine MPS SPECT. Due to a downward displacement 
of the diaphragm relative to the myocardium in the prone 
position, inferior wall artifacts are decreased. Moreover, the 
close contact of the anterior portion of the chest to the imag-
ing table reduces patient motion. Prone imaging was initially 
described in 1988.15 One year later, Esquerre et al16 and Segall 
et al17 demonstrated that, for 201Tl MPS, imaging patients in the 
prone position improved the specificity in evaluating inferior 
wall abnormalities, by minimizing diaphragmatic attenuation. 
Another study estimated an overall specificity and sensitiv-
ity of 80% and 93% respectively, for prone SPECT.18 The 
authors concluded that this approach should be considered 
when inferior wall defects on supine imaging pose a diagnostic 
dilemma and when motion on supine imaging necessitates 
repeat acquisition. Prone SPECT cannot, however, replace the 
traditional supine acquisition, because it has been reported 
to produce more artifactual anteroseptal defects, probably 
due to the closer position of the heart to the bony structures 
of the anterior chest wall.18 Prone SPECT should be utilised 
and interpreted as an adjunct to the supine stress acquisition, 
in order to reduce false-positive MPS findings.
A significant study by Hayes et al,19 regarding the prognos-
tic implications of combined supine-prone SPECT was pub-
lished in 2003. More than 3800 patients were included in this 
study. Three-hundred sixty-eight patients had normal prone 
and supine studies and the annual hard cardiac event rate was 
calculated at only 0.7% for this group. Conclusively, patients 
with negative results on additional prone SPECT showed a 
benign prognosis with a low rate of annual major adverse 
cardiac events (less than 1%) similar to those who had negative 
results on conventional supine SPECT. Thus, negative results 
by adding prone acquisition, not only increase specificity, but 
also indicate event-free survival. An invited commentary20 
published in the same year, advised the use of prone SPECT 
as a supplementary tool for conventional supine SPECT, to 
improve diagnostic specificity at the inferior wall.
A similar study, conducted in our department, revealed 
comparable results. Three-hundred eighty-six patients, 
without prior history of CAD were identified as having infe-
rior only or anterior only perfusion defects. These patients 
were mainly men (82%) and the vast majority of the defects 
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(94.5%) had been noted in the inferior wall. Follow-up of 18.5 
± 6 months was achieved in 344 out of 367 patients who had 
been interpreted as having a normal combined supine-prone 
SPECT study. No major cardiac events were observed in any 
of these 344 patients; while only one patient of this group had 
an angioplasty performed 16 months post MPS. We concluded 
that patients with negative combined supine-prone SPECT 
seem to carry a low risk for subsequent major cardiac events.12 
Additional recent evidence supports the improved diagnostic 
performance of MPS SPECT, by adding prone acquisition. 
Nishina et al7 applied quantification analysis in polar maps of 
stress images of a large group of 650 patients. They found out 
that combined supine-prone SPECT were more accurate, as 
measured by the area under the curve of respective receiver-
operating-characteristic (ROC) curves, than supine only and 
prone only SPECT in identification of ≥70% coronary vessel 
stenosis. Combined SPECT improved specificity of supine 
SPECT from 65% to 86% and yielded higher normalcy rates in 
obese patients. We note that the term “normalcy rate”, which 
is frequently mentioned in MPS studies, has been developed to 
correct for the test’s referral bias on true specificity. Normalcy 
rate is used to describe the frequency of normal test results 
in patients with a low likelihood of CAD, to differentiate it 
from specificity. The same research group applied this quan-
titative combined prone-supine SPECT algorithm in a large 
group of female population to counteract for breast artifacts.22 
Results were validated by coronary angiography. Combined 
supine-prone quantitative SPECT in women yielded signifi-
cantly increased specificity (94%) and normalcy rates without 
compromising sensitivity for the detection of CAD compared 
with standard supine SPECT.
Prone SPECT can be performed in conjunction with su-
pine gated SPECT, as has been shown by Berman et al.23 This 
combination has been found to achieve a reasonable diagnostic 
accuracy, no matter if the patient is overweight or even obese. 
In a recent study, designed to compare computed tomography 
(CT)-based attenuation correction (with hybrid SPECT/CT) 
with prone SPECT, the latter method was found to decrease 
equivocal MPS findings substantially to a percentage of 18% of 
the total number of studies.24 However, CT-based attenuation 
correction has been proven to be superior to prone imaging 
by reducing the equivocal findings even more to 11%. Bear-
ing in mind the limitations of attenuation correction maps via 
SPECT/CT, namely the expensive system requirement and its 
relative unavailability, prone SPECT remains the most practi-
cal, feasible and efficient means of increasing MPS specificity, 
by reducing attenuation artefacts.
C O N C l U S I O N
The addition of prone acquisition to traditional supine 
MPS SPECT has been proven to be an easy and efficient 
way to reduce attenuation artifacts (concerning mainly the 
inferior wall) and consequently increase the specificity of 
MPS. Prone SPECT requires only an additional acquisition 
of approximately 10 minutes and it can be performed on virtu-
ally any SPECT camera. It is costless, it does not implement 
additional hardware-software and most importantly it can be 
tolerated by the vast majority of patients. These reasons have 
rendered combined supine-prone SPECT a routine technique 
in our institution.
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